(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.

about

(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q40770857

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

(18)F-FDG and (18)F-NaF PET/CT ...... nover in rheumatoid arthritis.

@en

type

Item

label

(18)F-FDG and (18)F-NaF PET/CT ...... nover in rheumatoid arthritis.

@en

prefLabel

(18)F-FDG and (18)F-NaF PET/CT ...... nover in rheumatoid arthritis.

@en

P1476

(18)F-FDG and (18)F-NaF PET/CT ...... nover in rheumatoid arthritis.

@en

P2093

Akiko Suda

http://www.w3.org/2001/XMLSchema#string

Atsuhisa Ueda

http://www.w3.org/2001/XMLSchema#string

Atsushi Ihata

http://www.w3.org/2001/XMLSchema#string

Daiga Kishimoto

http://www.w3.org/2001/XMLSchema#string

Kaoru Takase-Minegishi

http://www.w3.org/2001/XMLSchema#string

Maasa Hama

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Takeno

http://www.w3.org/2001/XMLSchema#string

Reikou Kamiyama

http://www.w3.org/2001/XMLSchema#string

Shigeru Ohno

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs.

Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.

High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.

Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs

P304

180-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14397595.2015.1069458

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryusuke Yoshimi

Yohei Kirino

Yosuke Kunishita

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26140472

http://www.w3.org/2001/XMLSchema#string